Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression

被引:53
作者
Hoogendijk, Witte J. G. [1 ,2 ]
Meynen, Gerben [1 ,2 ]
Endert, Erik [3 ]
Hofman, Michel A. [1 ]
Swaab, Dick F. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Res Inst Neurosci, Dept Psychiat, NL-1075 BG Amsterdam, Netherlands
[2] Netherlands Inst Brain Res, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands
关键词
Alzheimer's disease; Post mortem; Depression; Cortisol; Hypothalamo-pituitary-adrenal axis;
D O I
10.1016/j.neurobiolaging.2005.07.017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Hypothalamo-pituitary-adrenal (HPA)-axis hyperactivity is well established in a large proportion of both Alzheimer's disease (AD) patients and idiopathic depression patients, resulting in, e. g. increased cerebrospinal fluid (CSF) cortisol levels. We hypothesized that HPA-axis activity in depressed AD patients is even more increased than in non-depressed AD patients, resulting in higher CSF cortisol levels. Cortisol levels were measured in post mortem CSF of depressed and non-depressed AD patients and in controls. Cortisol levels in AD patients were more than double those of controls, while no significant differences were found between depressed and non-depressed AD patients. These results suggest a different pathogenetic mechanism in depression in AD than in idiopathic depression. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:780.e1 / 780.e2
页数:2
相关论文
共 50 条
  • [21] Cerebrospinal fluid biomarkers of Alzheimer’s disease
    Xiaojing Sui
    Jianjun Liu
    Xifei Yang
    Neuroscience Bulletin, 2014, 30 : 233 - 242
  • [22] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [23] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
    Blennow, Kaj
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 413 - 417
  • [24] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Sui, Xiaojing
    Liu, Jianjun
    Yang, Xifei
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 233 - 242
  • [25] Cerebrospinal fluid lipoproteins in Alzheimer's disease
    Bassett, CN
    Montine, KS
    Neely, MD
    Swift, LL
    Montine, TJ
    MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 50 (04) : 282 - 286
  • [26] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Xiaojing Sui
    Jianjun Liu
    Xifei Yang
    Neuroscience Bulletin, 2014, 30 (02) : 233 - 242
  • [27] Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer's Disease
    Enache, Daniela
    Pereira, Joana B.
    Jelic, Vesna
    Winblad, Bengt
    Nilsson, Per
    Aarsland, Dag
    Bereczki, Erika
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (03) : 1143 - 1155
  • [28] Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD
    Sanfilippo, Cristina
    Forlenza, Orestes
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (12) : 1443 - 1447
  • [29] Increased Selenoprotein P in Choroid Plexus and Cerebrospinal Fluid in Alzheimer's Disease Brain
    Rueli, Rachel H. L. H.
    Parubrub, Arlene C.
    Dewing, Andrea S. T.
    Hashimoto, Ann C.
    Bellinger, Miyoko T.
    Weeber, Edwin J.
    Uyehara-Lock, Jane H.
    White, Lon R.
    Berry, Marla J.
    Bellinger, Frederick P.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 379 - 383
  • [30] Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
    Arlt, Soenke
    Schulze, Friedrich
    Eichenlaub, Martin
    Maas, Renke
    Lehmbeck, Jan T.
    Schwedhelm, Edzard
    Jahn, Holger
    Boeger, Rainer H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (01) : 58 - 64